Frederic Barabe

Quebec, QC G1V4G2, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference.

Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference.

Journal: Current oncology (Toronto, Ont.)
Published: October 02, 2025

Modeling KRAS mutations in KMT2A::MLLT3 acute myeloid leukemia promotes leukemic progression and transcriptional rewiring.

Modeling KRAS mutations in KMT2A::MLLT3 acute myeloid leukemia promotes leukemic progression and transcriptional rewiring.

Journal: Leukemia
Published: July 21, 2025

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.

Journal: Transplantation and cellular therapy
Published: June 10, 2025

Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study.

Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study.

Journal: Leukemia & lymphoma
Published: August 12, 2024

Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.

Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.

Journal: Leukemia
Published: December 12, 2023

Immunotherapeutic targeting of surfaceome heterogeneity in AML.

Immunotherapeutic targeting of surfaceome heterogeneity in AML.

Journal: Cell reports
Published: October 05, 2023

Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence.

Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence.

Journal: Blood advances
Published: May 01, 2023

CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.

CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.

Journal: Blood advances
Published: September 08, 2022

Harnessing Macrophages through the Blockage of CD47: Implications for Acute Myeloid Leukemia.

Harnessing Macrophages through the Blockage of CD47: Implications for Acute Myeloid Leukemia.

Journal: Cancers
Published: November 09, 2021

Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.

Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.

Journal: Blood advances
Published: August 30, 2021

VLA-4 Induces Chemoresistance of T Cell Acute Lymphoblastic Leukemia Cells via PYK2-Mediated Drug Efflux.

VLA-4 Induces Chemoresistance of T Cell Acute Lymphoblastic Leukemia Cells via PYK2-Mediated Drug Efflux.

Journal: Cancers
Published: May 07, 2021

Innate and adaptive immune responses toward nanomedicines.

Innate and adaptive immune responses toward nanomedicines.

Journal: Acta pharmaceutica Sinica. B
Published: December 06, 2020
Showing 1-12 of 31

Last Updated: 09/26/2026